Brief Reports
Copyright ©The Author(s) 2004.
World J Gastroenterol. Aug 1, 2004; 10(15): 2284-2286
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2284
Figure 1
Figure 1 HbA1c level and fructosamine concentration in pa-tients with liver disease. CC: Compensated cirrhosis; LF: Chronic hepatitis (liver fibrosis); IR: Chronic hepatitis with interferon and ribavirin treatment. Shaded areas represent the mean ± 2SD reference range for each test (HbA1c: 4.5-5.7%; fructosamine: 200-272 μmol/L)